Literature DB >> 17710498

Recurrence and prognostic factors of ampullary carcinoma after radical resection: comparison with distal extrahepatic cholangiocarcinoma.

Sang Myung Woo1, Ji Kon Ryu, Sang Hyub Lee, Ji Won Yoo, Joo Kyung Park, Yong-Tae Kim, Jin-Young Jang, Sun-Whe Kim, Gyeong Hoon Kang, Yong Bum Yoon.   

Abstract

BACKGROUND: Ampullary carcinoma is often considered to have a better prognosis than distal extrahepatic cholangiocarcinoma. However, studies that directly compare the recurrence and histopathological features between the two groups are rare.
METHODS: Clinicopathologic factors and the long-term outcomes of 163 patients with ampullary carcinoma after radical resection were retrospectively evaluated and compared with those of 91 patients with distal extrahepatic cholangiocarcinoma.
RESULTS: Among the 163 ampullary carcinomas, T1 stage, well-differentiated tumors and perineural invasion were 45 (28%), 73 (45%), and 23 (14%), respectively, whereas, only five (6%) were T1 stage, 15 (17%) were well differentiated, and 63 (69%) showed perineural invasion (p < 0.001, for all) in distal extrahepatic cholangiocarcinomas. More patients with distal extrahepatic cholangiocarcinoma had liver metastasis than ampullary carcinoma (24% vs. 10%, p = 0.004). Multivariate analysis identified venous invasion and perineural invasion as risk factors for recurrence of ampullary carcinoma after radical resection. Only lymph node involvement was identified as a risk factor for recurrence of distal extrahepatic cholangiocarcinoma by multivariate analysis. Overall five-year survival of patients with ampullary cancer was higher than that of patients with distal extrahepatic cholangiocarcinoma (68% vs. 54%; p = 0.033). In patients without lymph node metastasis, a significant difference in survival was also observed between the two groups (p = 0.049).
CONCLUSION: Earlier diagnosis and the less frequent occurrence of pathological factors associated with tumor invasiveness in ampullary carcinoma than in distal extrahepatic cholangiocarcinoma may explain its association with a better prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 17710498     DOI: 10.1245/s10434-007-9537-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  41 in total

1.  A Novel Prognostic Score Combining Preoperative Biliary Drainage and Inflammatory Status for Patients with Periampullary Cancers.

Authors:  Yuki Fujiwara; Koichiro Haruki; Ryoga Hamura; Takashi Horiuchi; Yoshihiro Shirai; Kenei Furukawa; Takeshi Gocho; Hiroaki Shiba; Katsuhiko Yanaga
Journal:  J Gastrointest Surg       Date:  2019-05-06       Impact factor: 3.452

2.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

3.  Metallic or plastic stent for bile duct obstruction in ampullary cancer?

Authors:  Su Bum Park; Hyung Wook Kim; Dae Hwan Kang; Cheol Woong Choi; Je Ho Ryu; Chong Woo Chu; Soo Yong Lee; Young Il Jeong; Hye Ju Yeo; Eun Jung Kim
Journal:  Dig Dis Sci       Date:  2011-09-23       Impact factor: 3.199

4.  Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor.

Authors:  Haixia Yang; Jiupeng Zhou; Xin Wei; Fan Wang; Huadong Zhao; Enxiao Li
Journal:  Mol Clin Oncol       Date:  2014-08-07

5.  Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.

Authors:  Serdar Balci; Olca Basturk; Burcu Saka; Pelin Bagci; Lauren M Postlewait; Takuma Tajiri; Kee-Taek Jang; Nobuyuki Ohike; Grace E Kim; Alyssa Krasinskas; Hyejeong Choi; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes; Jessica H Knight; Michael Goodman; Gizem Akkas; Michelle D Reid; Shishir K Maithel; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2015-03-18       Impact factor: 5.344

6.  A case of distal extrahepatic cholangiocarcinoma with two positive resection margins.

Authors:  Wayne A Warner; Wesley Ramcharan; Dave Harnanan; Srikanth Umakanthan; Ravi Maharaj
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

7.  Hepatic resection for liver metastases from carcinomas of the distal bile duct and of the papilla of Vater.

Authors:  Isao Kurosaki; Masahiro Minagawa; Chie Kitami; Kabuto Takano; Katsuyoshi Hatakeyama
Journal:  Langenbecks Arch Surg       Date:  2011-02-24       Impact factor: 3.445

Review 8.  Review of the investigation and surgical management of resectable ampullary adenocarcinoma.

Authors:  James Askew; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

9.  Hepatic metastasis from bile duct cancer of the ampulla is effectively controlled by multidisciplinary treatment including S-1, gemcitabine and bevacizumab: A case report.

Authors:  Yukihiko Tokunaga; Toshihiko Kawasaki; Hirokazu Sasaki; Shigeki Matsueda; Tohru Saito
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

10.  A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma.

Authors:  Christina L Roland; Matthew H G Katz; Graciela M N Gonzalez; Peter W T Pisters; Jean-Nicolas Vauthey; Robert A Wolff; Christopher H Crane; Jeffrey E Lee; Jason B Fleming
Journal:  J Gastrointest Surg       Date:  2012-08-23       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.